Few questions capture the engineering behind interventional cardiology as directly as how are stents made. A coronary stent looks deceptively simple — a small mesh tube — but reaching that final form involves a sequence of high-precision manufacturing steps, each validated under a certified quality system. This article walks through the general process at a conceptual, educational level.
What Raw Material Does Stent Manufacturing Start With?
Coronary stent manufacturing typically begins with a metal tube of a biocompatible alloy, commonly a cobalt-chromium alloy such as L605, chosen for its combination of strength, radiopacity, and corrosion resistance. Alloy selection affects strut thickness, since stronger materials can achieve adequate radial support with thinner struts — a design factor associated with lower profile delivery and potentially reduced vessel injury during deployment.
The starting tube's dimensions — outer diameter, wall thickness, and material grade — are tightly controlled specifications that feed directly into the subsequent cutting process.
How Does Laser Cutting Shape the Stent Pattern?
The stent's characteristic mesh geometry is created using precision laser cutting, in which a computer-controlled laser cuts an intricate strut pattern directly into the metal tube. This process defines the stent's mechanical behavior — its flexibility for navigating tortuous vessels, its radial strength for supporting the vessel wall, and its expansion characteristics during balloon deployment.
Design variations, such as open-cell versus closed-cell strut patterns, are established at this stage and are chosen based on the intended balance between flexibility and scaffolding support. Following laser cutting, stents typically undergo a cleaning step to remove cutting debris before moving to surface finishing.
What Does Electropolishing Do to the Stent Surface?
After laser cutting, the stent surface carries micro-roughness and residual material from the cutting process. Electropolishing is an electrochemical finishing technique that removes a controlled layer of material from the metal surface, smoothing sharp edges left by laser cutting and reducing surface irregularities.
A smoother, more uniform surface is associated with several manufacturing goals: reduced risk of surface-related complications, improved corrosion resistance, and a more consistent substrate for any subsequent coating application. Electropolishing parameters are validated and tightly controlled as part of the manufacturer's process qualification.
How Are Drug Coatings and Radiopaque Markers Applied?
For drug-eluting stents, a polymer-drug coating is applied to the finished metal scaffold in a separate, tightly controlled process, typically within a cleanroom environment. The coating is engineered to release a therapeutic agent — commonly an anti-proliferative drug such as sirolimus — at a controlled rate over time following implantation, intended to help reduce the risk of restenosis.
Separately, radiopaque markers, often made from platinum-iridium or similar dense metals, are incorporated at the stent's ends to allow visualization under fluoroscopic imaging during placement. Bare-metal stent variants follow a similar manufacturing pathway but omit the drug-coating step.
How Is Quality Verified Before a Stent Reaches Market?
Each stage of stent manufacturing is followed by inspection and testing against pre-defined specifications, all performed within an internationally recognized quality management standards-certified quality system. Testing typically includes dimensional verification, mechanical performance evaluation (such as radial strength and fatigue testing), coating uniformity assessment, and biocompatibility evaluation, before the finished device undergoes sterilization, packaging, and the conformity assessment supporting European market authorization under the applicable European medical device regulations.
Frequently Asked Questions
Why do stent strut thickness and material choice matter?
Strut thickness and alloy strength influence the stent's flexibility, radial support, and delivery profile. Thinner struts, enabled by stronger alloys, are generally associated with a lower-profile device, though the appropriate design depends on the specific clinical application.
Is every stent drug-eluting?
No. Both bare-metal and drug-eluting stent designs exist, and each follows a similar core manufacturing pathway with the coating step applied only to drug-eluting variants. The choice between them is a clinical decision made by the treating physician.
How is stent quality confirmed before it reaches a hospital?
Manufacturers perform dimensional, mechanical, coating, and biocompatibility testing under a certified quality management system, and devices undergo conformity assessment supporting European market authorization before distribution. Specific test data is documented in the manufacturer's technical file.
Related INVAMED Resources
- Explore INVAMED's Coronary Artery Disease & Cardiac Interventions product category
- Read our guide to Nitinol: The Shape-Memory Alloy in Medical Devices
- Learn about Cleanroom Manufacturing for Medical Devices Explained
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.